Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 2611 AL 2625

Antimuscarinic Anticholinergic Medications in Parkinson Disease: To Prescribe or Deprescribe?

Barrett MJ, Sargent L, Nawaz H, Weintraub D, Price ET, Willis AW.

Mov Disord Clin Pract. 2021 Oct 8;8(8):1181-1188. doi: 10.1002/mdc3.13347. eCollection 2021 Nov.

Antidepressants Effects on Pain in Parkinson Disease: A Systematic Review

Anghelescu BA, Todoran R, Terroba-Chambi C, Bruno V.

Clin Neuropharmacol. 2021 Nov-Dec 01;44(6):210-215. doi: 10.1097/WNF.0000000000000483.

Targetable Pathways for Alleviating Mitochondrial Dysfunction in Neurodegeneration of Metabolic and Non-Metabolic Diseases

Millichap LE, Damiani E, Tiano L, Hargreaves IP.

Int J Mol Sci. 2021 Oct 23;22(21):11444. doi: 10.3390/ijms222111444.

The Effect of Physical Exercise on Cognitive Impairment in Neurodegenerative Disease: From Pathophysiology to Clinical and Rehabilitative Aspects

Farì G, Lunetti P, Pignatelli G, Raele MV, Cera A, Mintrone G, Ranieri M, Megna M, Capobianco L.

Int J Mol Sci. 2021 Oct 27;22(21):11632. doi: 10.3390/ijms222111632.

Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?

Pinheiro RGR, Coutinho AJ, Pinheiro M, Neves AR.

Int J Mol Sci. 2021 Oct 28;22(21):11654. doi: 10.3390/ijms222111654.

Small Intestinal Bacterial Overgrowth as Potential Therapeutic Target in Parkinson's Disease

Dănău A, Dumitrescu L, Lefter A, Tulbă D, Popescu BO.

Int J Mol Sci. 2021 Oct 28;22(21):11663. doi: 10.3390/ijms222111663.

Mechanistic Insight from Preclinical Models of Parkinson's Disease Could Help Redirect Clinical Trial Efforts in GDNF Therapy

Delgado-Minjares KM, Martinez-Fong D, Martínez-Dávila IA, Bañuelos C, Gutierrez-Castillo ME, Blanco-Alvarez VM, Cardenas-Aguayo MD, Luna-Muñoz J, Pacheco-Herrero M, Soto-Rojas LO.

Int J Mol Sci. 2021 Oct 28;22(21):11702. doi: 10.3390/ijms222111702.

Neurodegenerative Disorders: Spotlight on Sphingolipids

Mandik F, Vos M.

Int J Mol Sci. 2021 Nov 5;22(21):11998. doi: 10.3390/ijms222111998.

Focus on the Small GTPase Rab1: A Key Player in the Pathogenesis of Parkinson's Disease

Martínez-Menárguez JÁ, Martínez-Alonso E, Cara-Esteban M, Tomás M.

Int J Mol Sci. 2021 Nov 8;22(21):12087. doi: 10.3390/ijms222112087.

Particulate Air Pollution and Risk of Neuropsychiatric Outcomes. What We Breathe, Swallow, and Put on Our Skin Matters

Calderón-Garcidueñas L, Stommel EW, Rajkumar RP, Mukherjee PS, Ayala A.

Int J Environ Res Public Health. 2021 Nov 3;18(21):11568. doi: 10.3390/ijerph182111568.

Music Therapy and Parkinson's Disease: A Systematic Review from 2015-2020

Machado Sotomayor MJ, Arufe-Giráldez V, Ruíz-Rico G, Navarro-Patón R.

Int J Environ Res Public Health. 2021 Nov 4;18(21):11618. doi: 10.3390/ijerph182111618.

Application of Deep Learning Models for Automated Identification of Parkinson's Disease: A Review (2011-2021)

Loh HW, Hong W, Ooi CP, Chakraborty S, Barua PD, Deo RC, Soar J, Palmer EE, Acharya UR.

Sensors (Basel). 2021 Oct 23;21(21):7034. doi: 10.3390/s21217034.

Neuroprotective Potential of Chrysin: Mechanistic Insights and Therapeutic Potential for Neurological Disorders

Mishra A, Mishra PS, Bandopadhyay R, Khurana N, Angelopoulou E, Paudel YN, Piperi C.

Molecules. 2021 Oct 26;26(21):6456. doi: 10.3390/molecules26216456.

Enhanced Electrocatalytic Detection of Choline Based on CNTs and Metal Oxide Nanomaterials

Uwaya GE, Fayemi OE.

Molecules. 2021 Oct 28;26(21):6512. doi: 10.3390/molecules26216512.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias